Patent Number: 7,612,183

Title: Humanised anti-mag antibody or functional fragment thereof

Abstract: The present invention relates to altered antibodies to myelin associated glycoprotein (MAG), pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorders.

Inventors: Ellis; Jonathan Henry (Stevenage, GB), Germaschewski; Volker (Stevenage, GB)

Assignee: Glaxo Group Limited

International Classification: C12P 21/08 (20060101); A61K 39/395 (20060101)

Expiration Date: 1/03/02017